Prevalence and risk factors associated with resistance-associated mutations to etravirine in a cohort of perinatally HIV-infected children

Etravirine is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with reduced cross-resistance to first-generation NNRTIs. Because many perinatally HIV-infected patients have been treated with first-generation NNRTIs, they may have acquired resistance-associated mutations to...

Full description

Autores:

Contreras, German A.
Bell, Cynthia S.
Del Bianco, Gabriela P.
Pérez, Norma
Kleinosky, Matthew T.
Murphy, James R.
Heresi, Gloria P.

Tipo de recurso:

Article of journal

Fecha de publicación:

2013

Institución:

Universidad El Bosque

Repositorio:

Repositorio U. El Bosque

Idioma:

eng

OAI Identifier:

oai:repositorio.unbosque.edu.co:20.500.12495/3584

Acceso en línea:

http://hdl.handle.net/20.500.12495/3584
https://doi.org/10.1093/jac/dkt198
https://repositorio.unbosque.edu.co

Palabra clave:

Antivirales
VIH
Niño
Therapy adherence
Cumulative HIV RNA
Hispanics

Rights

openAccess

License

Acceso abierto